Last updated on May 2020

HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

Brief description of study

The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant is safe with regards to major transplant-related and HIV-related complications

Detailed Study Description

This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted an HIVD- organ will be randomized to be followed in the full study or followed in the nested observational group

Clinical Study Identifier: NCT03734393

Find a site near you

Start Over

University of Miami

Miami, FL United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Ochsner Clinic Foundation

New Orleans, LA United States
  Connect »

Johns Hopkins University

Baltimore, MD United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »

University of Cincinnati

Cincinnati, OH United States
  Connect »

University of Pennsylvania

Philadelphia, PA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.